The ALS PhaseI/II safety trial of Brainstorm Cell Therapeutics’ NurOwn stem cell therapy has been fast tracked to a Phase IIa dose-escalating trial by Israel’s Ministry of Health and will be launched “immediately” at the Hadassah Medical Center, reports this leading developer of adult stem cell technologies for neurodegenerative diseases.
In treating a patient who suffered from massive congestive heart failure and a malfunctioning liver, Dr. Yuval Horwich, a resident in the department of internal medicine at the Hadassah Medical Center, discovered that the man had eaten a poisonous mushroom, which he had picked in the Jerusalem forest.
A woman with a malignant melanoma who was treated at the Hadassah Medical Center wrote to say that her Hadassah surgeon cared for her “with endless devotion.”
Researchers at the Hadassah Medical Center are investigating the connection between lower levels of the hormone, oxytocin, during pregnancy and the development of autism.
Israeli researchers, led by Dr. Asher Salmon, then Senior Oncologist at the Hadassah Medical Center, developed a blood test that reveals it is possible to predict the presence of harmful BRCA1 and BRCA2 mutations in otherwise healthy women using a novel technology called gene expression profiling.
After being told there was no treatment that could save him, a Florida attorney with stage four melanoma received a new lease on life when he was accepted into a personally tailored melanoma vaccine clinical trial at the Hadassah Medical Center.
To empower and encourage women to make life choices that will preserve a healthy heart, the Hadassah Medical Center has received a ten-million dollar gift to create the Linda Joy Pollin Cardiovascular Wellness Institute.
Identifying the defective gene that has caused neuropathy in children of North African descent, physician/researchers at the Hadassah Medical Center have employed an experimental drug to prevent permanent paralysis of both muscle and vocal cords in four children.
Professor Shimon Reif, a specialist in pediatrics and pediatric gastroenterology who recently headed the Department of Pediatrics at the Dana-Dwek Children’s Hospital of the Tel Aviv Sourasky Medical Center, has been appointed head of Pediatrics at Hadassah Hospital-Ein Kerem. He is replacing Prof. Dan Engelhard, who has completed 10 years in the role and will now serve as head of Hadassah’s Pediatric Infectious Diseases Unit.
To develop a unique stent locator based on the work of three Hadassah Medical Center heart specialists, Hadasit, Hadassah’s Technology Transfer Company, has created an incubator company entitled AOL Medical.